Cipla announces closure of USFDA inspection at Patalganga facility
Business | January 20, 2020 16:25 ISTCipla on Monday announced the closure of inspection by the US health regulator at its Patalganga manufacturing facility in Maharashtra.
Cipla on Monday announced the closure of inspection by the US health regulator at its Patalganga manufacturing facility in Maharashtra.
The government on Monday sought vacation of Delhi High Court's interim order staying the ban on some fixed dose combinations (FDC) medicines, saying it would be "against public interest and patient safety"
New Delhi: Pharmaceutical firm Cipla on Thursday announced that its UK arm, Cipla (EU) has closed the $550 million (approximately Rs 3,650 crore) deal to acquire two US-based firms, InvaGen Pharmaceuticals and Exelan Pharmaceuticals.The acquisition
Drug major Cipla today announced the launch of generic drug Sofosbuvir for treating chronic Hepatitis C under the brand name 'Hepcvir', in India."Following the non-exclusive licensing agreement signed with Gilead Sciences in September last year
Mumbai: Hamsons, a firm owned by the promoter family of pharmaceuticals major Cipla, has bought out the remaining 21 per cent equity owned by minority shareholders in Satara-based Okasa Pharma for an undisclosed amount, completing
Mumbai: Shares of drug major Cipla fell almost three per cent today after the company's September quarter results came in below market expectations.Cipla's scrip lost 2.93 per cent to Rs 605.85 at the BSE. At
New Delhi: Generic drugmaker Cipla has requested the NDA government to revoke five patents held by Swiss firm Novartis AG on respiratory drug Onbrez.The move would help the company to boost its access in the
New Delhi: Drugmaker Cipla today announced a collaboration with Israel's Teva Pharmaceuticals for sales and distribution of the latter's drugs in South Africa.The agreement is between Medpro Pharmaceuticals, a subsidiary of Cipla Medpro and Teva
New Delhi: Continuing its overseas acquisitions, pharma major Cipla has inked a pact with a Yemeni firm to acquire its majority stake for USD 21 million (over Rs 125 crore). The company has signed a
New Delhi: Drug firm Cipla Ltd on Monday said it will acquire 14.6 percent stake in US-based Chase Pharmaceuticals Corporation Inc for USD 1.5 million.The investment will be done through Cipla's wholly owned subsidiary Cipla
New Delhi: Cipla Chairman Yousuf K Hamied has said India can be a global leader in supplying affordable and high quality medicines to the world, especially to the underdeveloped countries where such medicines do not
New Delhi: India can be a global leader in supplying affordable and high quality medicines to the world, and especially to the underdeveloped countries where such medicines do not reach the poor because of their
New Delhi, Jul 31: Delhi High Court yesterday extended the operation of its earlier order asking the Centre not to take coercive steps against pharma major Cipla Ltd which was told to replace stocks in
New Delhi, Jan 13: Drug major Cipla has said state-run Life Insurance Corporation has sold 2.12 per cent stake in it through open market transactions for Rs 665.39 crore.The insurer has reduced its stake to
New Delhi, Nov 8: Giving some relief to cancer patients, pharma major Cipla today slashed prices of its three generic cancer drugs by up to 64 per cent.Drugs under the brand names Erlocip, Docetax and
New Delhi, Nov 5: Drug firm Cipla Ltd on Monday said its consolidated net profit rose by 61.83 per cent to Rs 500.01 crore for the second quarter ended September 30, 2012, due to robust
New Delhi, Oct 4: Drug firm Cipla on Thursday said an anti-malarial drug developed by Drugs for Neglected Diseases initiative (DNDi) has received pre-qualification from the World Health Organisation (WHO).The Mumbai-headquartered firm is manufacturing the
Mumbai, Aug 25: Pharma major Cipla today said it is expecting to scale up its revenue by over six times to Rs 15,000-20,000 crore by 2020 and assured shareholders the promoters have no plan to
Top News
Latest News
